Table 2
Open in new tab

Comparison of the electrocardiographic characteristics

Group-A (n = 8)Group-B (n = 17)P
QRS duration (ms)127 ± 6124 ± 50.23
Precordial R-wave transition
 V2–V3410
 V3–V447
Mean R-wave amplitude in inferior leads (mV)1.12 ± 0.320.71 ± 0.240.002
Voltage ratio lead III/II0.77 ± 0.100.50 ± 0.230.005
R-wave amplitude in lead I >0.5 mV2/8 (25%)14/17 (82%)0.010
R-wave amplitude in lead I (mV)0.43 ± 0.180.67 ± 0.190.005
R-wave in lead aVL6/8 (75%)16/17 (94%)0.23
S-wave in lead III1/8 (13%)16/17 (94%)<0.001
QS in lead V13/8 (38%)17/17 (100%)0.001
Group-A (n = 8)Group-B (n = 17)P
QRS duration (ms)127 ± 6124 ± 50.23
Precordial R-wave transition
 V2–V3410
 V3–V447
Mean R-wave amplitude in inferior leads (mV)1.12 ± 0.320.71 ± 0.240.002
Voltage ratio lead III/II0.77 ± 0.100.50 ± 0.230.005
R-wave amplitude in lead I >0.5 mV2/8 (25%)14/17 (82%)0.010
R-wave amplitude in lead I (mV)0.43 ± 0.180.67 ± 0.190.005
R-wave in lead aVL6/8 (75%)16/17 (94%)0.23
S-wave in lead III1/8 (13%)16/17 (94%)<0.001
QS in lead V13/8 (38%)17/17 (100%)0.001
Table 2
Open in new tab

Comparison of the electrocardiographic characteristics

Group-A (n = 8)Group-B (n = 17)P
QRS duration (ms)127 ± 6124 ± 50.23
Precordial R-wave transition
 V2–V3410
 V3–V447
Mean R-wave amplitude in inferior leads (mV)1.12 ± 0.320.71 ± 0.240.002
Voltage ratio lead III/II0.77 ± 0.100.50 ± 0.230.005
R-wave amplitude in lead I >0.5 mV2/8 (25%)14/17 (82%)0.010
R-wave amplitude in lead I (mV)0.43 ± 0.180.67 ± 0.190.005
R-wave in lead aVL6/8 (75%)16/17 (94%)0.23
S-wave in lead III1/8 (13%)16/17 (94%)<0.001
QS in lead V13/8 (38%)17/17 (100%)0.001
Group-A (n = 8)Group-B (n = 17)P
QRS duration (ms)127 ± 6124 ± 50.23
Precordial R-wave transition
 V2–V3410
 V3–V447
Mean R-wave amplitude in inferior leads (mV)1.12 ± 0.320.71 ± 0.240.002
Voltage ratio lead III/II0.77 ± 0.100.50 ± 0.230.005
R-wave amplitude in lead I >0.5 mV2/8 (25%)14/17 (82%)0.010
R-wave amplitude in lead I (mV)0.43 ± 0.180.67 ± 0.190.005
R-wave in lead aVL6/8 (75%)16/17 (94%)0.23
S-wave in lead III1/8 (13%)16/17 (94%)<0.001
QS in lead V13/8 (38%)17/17 (100%)0.001
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close